More General News
View Older Stories View Newer Stories-
Microsoft offers buyouts to 60,000 workers as AI reshapes workforce
-
CACI rallies on $281M Navy electronic warfare order, Jefferies upgrade
-
Nanobiotix stock gains on positive melanoma trial data
-
Top Utilities Stocks to Watch: HSBC’s Preferred Picks
-
Citi reiterates buy rating on AppLovin with $500 target
-
Wells Fargo Highlights Top Shopping Center REITs Ahead of Q3 Earnings
-
Xencor stock surges on positive cancer drug trial data
-
UBS on Amazon: Street’s AWS margin estimates for 2027 are too low
-
BTIG reiterates neutral rating on Hershey ahead of Q3 results
-
Jefferies finds Article 8 funds lead Europe's 2026 launches
-
Jefferies Names Top European Mid-Cap IT Stocks After the Latest Update
-
New Street bullish on Intel to Buy as CPU scarcity strengthens turnaround
-
Citi reiterates Buy rating on Herc Holdings amid CEO transition
-
Morgan Stanley sees limited upside for Block as credit risks rise
-
How crowded are hardware and chip stocks into Q4?
-
Citi reiterates Buy rating on Roblox with $60 price target
-
Howard Hughes stock surges on S&P SmallCap 600 addition
-
Netanyahu rejects reports of potential escalation with Iran before elections - AP
-
Ross Stores climbs as UBS upgrades shares to Buy on stronger sales outlook
-
Morgan Stanley upgrades Lockheed Martin, says F-35 deal removes key risk
-
Ovintiv stock dips as $890M Logan Energy deal announced
-
Citi Names Top Picks in European Energy Services Amid Mideast Shift
-
Apollo nears deal to buy 10% stake in Mubadala Capital, CNBC reports
-
Goldman cuts Norsk Hydro as falling premiums, rising costs weigh
-
New survey reveals Wall Street's consensus S&P 500 targets for end of 2026
-
Dow Jones, Nasdaq, S&P 500 weekly preview: Markets brace for pivotal earnings week
-
Anthropic said to plan 9 a.m. S-1 filing as mid-November IPO remains on track
-
Why Ed Yardeni says the best market entry points are still to come
-
Cemex stock rises 3% on third quarter earnings and revenue beat
-
MakeMyTrip stock rises 4% on profit view despite revenue miss
-
Acumen Pharmaceuticals beats Q3 estimates, shares jump 6%
-
Avio shares gain 4% as Berenberg sees sustained demand for rocket motors
-
Can French stocks rebound despite persistent political risks? JPM weighs in
-
Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
-
HSBC turns cautious short-term on stocks but remains bullish for 2027
-
Deutsche Bank flags bigger-than-expected UK investment push ahead of Budget
-
AI investment boom now trails the 1990s tech cycle
-
Apollo To Buy Nearly 10% Stake In Mubadala Capital - CNBC
-
Meta reverses losses to rise as investors weigh $35 billion AI funding plan
-
Premarket movers: Moderna, Brazil ADRs drop; SpaceX rises
-
Verizon beats profit estimates, raises guidance
-
Citi sees Lula's election win as negative for Brazilian markets
-
Owens-Illinois stock rises ahead of earnings as Citi sees low bar
-
BNP Paribas comemnts on SpaceX talks with tower firms
-
Citi reiterates sell rating on Moderna with $80 price target
-
BofA sees value in credit tranches amid wider spreads
-
Wells Fargo cuts machinery targets on AI funding concerns
-
KeyBanc positive on Monolithic Power into earnings
-
KeyBanc postive on Intel into earnings
-
Raymond James sees AI financing opportunities for Apollo, Owl Rock and Ares
